AxoGen (NASDAQ:AXGN – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Friday. AXGN has been the topic of a number of other research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $12.00 price objective on shares of AxoGen […]
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Form SC 13G/A Axogen, Inc. Filed by: Soleus Capital Master Fund, L.P. streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2024 Axogen, Inc. , a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced making.
AxoGen, Inc. (NASDAQ:AXGN – Get Free Report) was the recipient of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 1,410,000 shares, a decrease of 37.9% from the December 31st total of 2,270,000 shares. Based on an average trading volume of 532,500 shares, the […]